Claims
- 1. A 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrate represented by the following formula (I): ##STR4## wherein n means a number in the range of from 1/2 to 3, said hydrate having a water content of from approximately 2.5 to approximately 15.5% by weight as measured by the Karl Fischer method.
- 2. The 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrate according to claim 1, wherein n in formula (I) is 1/2, and the water content is from approximately 2.5 to approximately 3.1% by weight as measured by the Karl Fischer method.
- 3. The 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrate according to claim 1, wherein n in formula (I) is 3, and the water content is from 14.0 to approximately 15.5% by weight as measured by the Karl Fischer method.
- 4. A tablet comprising a compound of claim 1 as the active ingredient.
- 5. A tablet comprising a compound of claim 2 as the active ingredient.
- 6. A tablet comprising a compound of claim 3 as the active ingredient.
Priority Claims (1)
Number |
Date |
Country |
Kind |
7-167460 |
Jul 1995 |
JPX |
|
Parent Case Info
This application is a 371 of PCT/JP96/01698 filed Jun. 19, 1996.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/JP96/01698 |
6/19/1996 |
|
|
10/14/1997 |
10/14/1997 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/02260 |
1/23/1997 |
|
|
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4678783 |
Hidaka et al. |
Jul 1987 |
|
Foreign Referenced Citations (6)
Number |
Date |
Country |
61-152658 |
Jul 1986 |
JPX |
2-256617 |
Oct 1990 |
JPX |
4-278094 |
Oct 1992 |
JPX |
6-80569 |
Mar 1994 |
JPX |
6-293643 |
Oct 1994 |
JPX |
7-41424 |
Feb 1995 |
JPX |